Results 161 to 170 of about 52,329 (268)

The role of cancer‐associated fibroblasts in the tumour microenvironment of urinary system

open access: yesClinical and Translational Medicine, Volume 15, Issue 4, April 2025.
We summarised the role of cancer‐associated fibroblasts (CAFs) in urological tumours, including their origin, exosomes and extracellular matrix (ECM). CAFs are derived from various precursor cells and can communicate with other cells to form a hypoxic and immunosuppressive microenvironment.
Ri Hong   +7 more
wiley   +1 more source

Opportunistic Gulls Infected by Antibiotic‐Resistant Bacteria Show Contrasting Movement Behaviour

open access: yesEcology and Evolution, Volume 15, Issue 4, April 2025.
Our work addresses a major research gap in animal ecology and movement behaviour by investigating differences between infected and uninfected gull individuals with Escherichia coli. More specifically, we investigated differences in movement metrics by using high‐resolution GPS movement data.
Víctor Martín‐Vélez   +8 more
wiley   +1 more source

Light Irradiation of N‐Doped Graphene Acid: Metal‐Free Strategy Toward Antibacterial and Antiviral Coatings With Dual Modes of Action

open access: yesEcoMat, Volume 7, Issue 4, April 2025.
Antimicrobial resistance and new viral strains are rising threats. Metal‐based nanomaterials show promise but have side effects and debated effectiveness. A metal‐free approach using nitrogen‐doped graphene acid activated by near‐infrared light is proposed, achieving significant reductions in bacterial and viral spread without adverse effects, offering
Giacomo Reina   +11 more
wiley   +1 more source

From Diarrhea to Bacteremia: Extended-Spectrum Beta-Lactamase (ESBL)-Producing Shigella in a Rare Clinical Scenario. [PDF]

open access: yesCureus
Al-Anbagi U   +7 more
europepmc   +1 more source

Novel inhibitors of beta-lactamase [PDF]

open access: yesActa Crystallographica Section A Foundations and Advances, 2015
Vitaly G. Grigorenko   +8 more
openaire   +2 more sources

Risk of Serious Infections in Patients Treated With Biologic or Targeted‐synthetic Disease Modifying Antirheumatic Drugs in Qatar

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
This study investigates the risk of serious infections (SIs) in patients treated with biologic or targeted‐synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in Qatar. Out of 1092 patients, 86 (7.9%) experienced SIs, with adalimumab and infliximab associated with higher SI rates.
Sreethish Sasi   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy